Thomas Yau Selected Research

Thomas Yau Research Topics

Disease

65	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 01/2007
34	Neoplasms (Cancer) 02/2024 - 01/2007
8	Disease Progression 06/2023 - 01/2006
6	Liver Neoplasms (Liver Cancer) 12/2023 - 11/2008
6	Colorectal Neoplasms (Colorectal Cancer) 11/2023 - 04/2009
6	Breast Neoplasms (Breast Cancer) 09/2022 - 01/2006
6	Neoplasm Metastasis (Metastasis) 01/2019 - 11/2008
5	Hepatitis B 02/2023 - 01/2009
4	Hypertension (High Blood Pressure) 02/2024 - 07/2021
3	COVID-19 01/2024 - 01/2020
3	Infections 12/2022 - 06/2017
3	Fibrosis (Cirrhosis) 01/2021 - 11/2012
2	Vomiting 04/2024 - 12/2019
2	Nausea 04/2024 - 12/2019
2	Asthenia 04/2024 - 02/2024
2	Multiple Organ Failure (MODS) 02/2024 - 01/2022
2	Tumor Lysis Syndrome 02/2024 - 01/2022
2	Varicose Veins (Varicose Vein) 02/2024 - 01/2022
2	Hepatic Encephalopathy 02/2024 - 01/2022
2	Chemical and Drug Induced Liver Injury 02/2024 - 01/2022
2	Liver Diseases (Liver Disease) 12/2022 - 09/2022
2	Inflammation (Inflammations) 01/2022 - 12/2020
2	Hepatitis 01/2022 - 06/2017
2	Cholangiocarcinoma 01/2022 - 04/2014
2	Diarrhea 01/2020 - 12/2019
2	Thrombocytopenia (Thrombopenia) 01/2019 - 12/2013
2	Colonic Neoplasms (Colon Cancer) 11/2013 - 11/2012
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 03/2013 - 03/2010
2	Stomach Neoplasms (Stomach Cancer) 01/2013 - 01/2012
2	Carcinogenesis 01/2012 - 01/2009
2	Hemangiosarcoma (Angiosarcoma) 06/2011 - 04/2008
2	Thrombosis (Thrombus) 01/2009 - 11/2008
1	Fever (Fevers) 04/2024
1	Exanthema (Rash) 04/2024
1	Pruritus (Itching) 04/2024
1	Microsatellite Instability 02/2024
1	Melanoma (Melanoma, Malignant) 02/2024
1	Sepsis (Septicemia) 02/2024
1	Aspiration Pneumonia 01/2024
1	Renal Cell Carcinoma (Grawitz Tumor) 11/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2023
1	Malnutrition (Nutritional Deficiencies) 10/2023
1	Diabetes Mellitus 10/2023

Drug/Important Bio-Agent (IBA)

34	Sorafenib (BAY 43-9006)FDA Link 02/2024 - 01/2009
10	NivolumabIBA 01/2023 - 06/2017
9	cabozantinibIBA 02/2024 - 01/2020
9	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2012
8	pembrolizumabIBA 09/2023 - 01/2020
7	Bevacizumab (Avastin)FDA Link 02/2023 - 01/2009
6	atezolizumabIBA 02/2024 - 07/2020
6	Immune Checkpoint InhibitorsIBA 01/2023 - 06/2017
5	IpilimumabIBA 01/2023 - 11/2020
5	Trastuzumab (Herceptin)FDA Link 09/2022 - 01/2006
4	durvalumabIBA 12/2023 - 01/2021
4	tremelimumabIBA 12/2023 - 01/2021
4	alpha-Fetoproteins (alpha-Fetoprotein)IBA 02/2023 - 01/2011
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2023 - 01/2007
4	Tyrosine Kinase InhibitorsIBA 10/2021 - 01/2019
3	spartalizumabIBA 04/2024 - 06/2022
3	Monoclonal AntibodiesIBA 02/2024 - 01/2021
3	Aspartate Aminotransferases (Aspartate Transaminase)IBA 02/2024 - 01/2022
3	B7-H1 AntigenIBA 11/2023 - 09/2021
3	Capecitabine (Xeloda)FDA Link 01/2022 - 01/2014
3	Proteins (Proteins, Gene)FDA Link 09/2021 - 11/2008
2	capmatinibIBA 04/2024 - 01/2019
2	Alanine Transaminase (SGPT)IBA 02/2024 - 01/2022
2	VaccinesIBA 01/2023 - 12/2022
2	EpitopesIBA 12/2022 - 01/2020
2	AntibodiesIBA 12/2022 - 01/2022
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 01/2014
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2021 - 04/2008
2	neratinibIBA 10/2021 - 01/2020
2	LigandsIBA 09/2021 - 01/2021
2	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2020 - 11/2010
2	regorafenibIBA 01/2020 - 07/2017
2	Antiviral Agents (Antivirals)IBA 06/2017 - 03/2015
2	Cetuximab (Erbitux)FDA Link 01/2017 - 11/2013
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2016 - 04/2015
2	ArginaseIBA 04/2015 - 02/2013
2	Fluorouracil (Carac)FDA LinkGeneric 01/2014 - 04/2009
2	Leucovorin (Folinic Acid)FDA Link 01/2014 - 04/2009
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 11/2013 - 12/2012
2	NeuropeptidesIBA 03/2013 - 03/2010
1	Apoptosis Regulatory ProteinsIBA 02/2024
1	CS-1003IBA 02/2024
1	NIS-793IBA 11/2023
1	Insulin (Novolin)FDA Link 10/2023
1	Gemcitabine FDA Link 01/2023

Therapy/Procedure

36	Therapeutics 09/2023 - 11/2008
12	Drug Therapy (Chemotherapy) 01/2023 - 04/2008
3	Immunotherapy 12/2023 - 01/2021
3	Liver Transplantation 09/2022 - 02/2013
2	Neoadjuvant Therapy 12/2021 - 03/2019
2	Hepatectomy 01/2014 - 11/2013
2	Molecular Targeted Therapy 01/2013 - 09/2010
2	Adjuvant Chemotherapy 04/2010 - 04/2009
2	Radiotherapy 09/2008 - 10/2003
1	Traction 01/2024
1	Telerehabilitation 01/2024
1	Pancreatectomy 10/2023